179 related articles for article (PubMed ID: 36840341)
1. Detecting Donor-Derived DNA by Real-Time PCR in Recipients Suspected of Graft-Versus-Host-Diseases After Liver Transplantation: A Case Series and Literature Review.
Ha C; Kim SJ; Kim JM; Joh JW; Jang KT; Choi GS; Kang ES
Ann Transplant; 2023 Feb; 28():e938287. PubMed ID: 36840341
[TBL] [Abstract][Full Text] [Related]
2. The clinical impact of donor against recipient HLA one way mismatch on the occurrence of graft versus host disease in liver transplantation.
Kim SJ; Park S; Rhu J; Kim JM; Choi GS; Joh JW
Sci Rep; 2022 Nov; 12(1):20337. PubMed ID: 36434131
[TBL] [Abstract][Full Text] [Related]
3. Fatal Graft-Versus-Host Disease Following Adult-To-Adult Living Donor Liver Transplantation From an HLA Nonhomozygous Donor.
Yu YD; Kim DS; Ha N; Jung SW; Han JH; Kim JY; Park SH; Cho YJ
Prog Transplant; 2016 Dec; 26(4):394-396. PubMed ID: 27555077
[TBL] [Abstract][Full Text] [Related]
4. Graft-versus-host disease following living donor liver transplantation.
Soejima Y; Shimada M; Suehiro T; Hiroshige S; Gondo H; Takami A; Yasue S; Maehara Y
Liver Transpl; 2004 Mar; 10(3):460-4. PubMed ID: 15004778
[TBL] [Abstract][Full Text] [Related]
5. Acute Graft-vs-Host Disease After Liver Transplantation: Experience at a High-volume Liver Transplantation Center in Korea.
Kang WH; Hwang S; Song GW; Jung DH; Park GC; Ahn CS; Moon DB; Kim KH; Ha TY; Kim WJ; Kim SH; Cho HD; Kwon JH; Jwa EK; Lee SG
Transplant Proc; 2016 Dec; 48(10):3368-3372. PubMed ID: 27931583
[TBL] [Abstract][Full Text] [Related]
6. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
7. Graft-versus-Host Disease after Liver Transplantation: A Single-Center Case Series.
Elsiesy H; Ibrahim A; Selim K; Al Sebayel M; Broering D; Al Hamoudi W; Al Arieh R; Abaalkhail F
Ann Transplant; 2015 Jul; 20():397-401. PubMed ID: 26169190
[TBL] [Abstract][Full Text] [Related]
8. Graft-versus-host disease after living donor liver transplantation: an unpredictable troublesome complication for liver transplant centers.
Gonultas F; Akbulut S; Barut B; Kutluturk K; Yilmaz S
Eur J Gastroenterol Hepatol; 2020 Jan; 32(1):95-100. PubMed ID: 31524772
[TBL] [Abstract][Full Text] [Related]
9. Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease after liver transplantation.
Taylor AL; Gibbs P; Sudhindran S; Key T; Goodman RS; Morgan CH; Watson CJ; Delriviere L; Alexander GJ; Jamieson NV; Bradley JA; Taylor CJ
Transplantation; 2004 Feb; 77(3):441-6. PubMed ID: 14966423
[TBL] [Abstract][Full Text] [Related]
10. T-cell chimerism prior to graft-versus-host disease.
Noguchi M; Shindo T; Yamada Y; Date H
Eur J Cardiothorac Surg; 2021 Jul; 60(1):194-196. PubMed ID: 33495782
[TBL] [Abstract][Full Text] [Related]
11. Acute graft versus host disease following living donor liver transplantation: first Korean report.
Cho EH; Suh KS; Yang SH; Lee HW; Cho JY; Cho YB; Yi NJ; Lee KU
Hepatogastroenterology; 2007; 54(79):2120-2. PubMed ID: 18251173
[TBL] [Abstract][Full Text] [Related]
12. Fatal graft-versus-host disease after living-donor liver transplantation from an HLA-DR-mismatched donor.
Shimata K; Sakamoto R; Anan T; Uchida K; Honda M; Kouroki M; Urabe T; Hayashida S; Yamamoto H; Sugawara Y; Inomata Y
Pediatr Transplant; 2017 Nov; 21(7):. PubMed ID: 28834141
[TBL] [Abstract][Full Text] [Related]
13. Graft-Versus-Host Disease Following Liver Transplantation: Development of a High-Incidence Rat Model and a Selective Prevention Method.
Yu E; Ueta H; Kimura H; Kitazawa Y; Sawanobori Y; Matsuno K
Am J Transplant; 2017 Apr; 17(4):979-991. PubMed ID: 27732765
[TBL] [Abstract][Full Text] [Related]
14. Incidence and Risk Factors for Fatal Graft-versus-host Disease After Liver Transplantation.
Kitajima T; Henry M; Ivanics T; Yeddula S; Collins K; Rizzari M; Yoshida A; Abouljoud MS; Nagai S; Moonka D
Transplantation; 2021 Dec; 105(12):2571-2578. PubMed ID: 33449608
[TBL] [Abstract][Full Text] [Related]
15. Lethal acute graft-versus-host disease in a liver transplant recipient: relations with cell migration and chimerism.
Pageaux GP; Perrigault PF; Fabre JM; Portales P; Souche B; Dereure O; Eliaou JF; Larrey D; Domergue J; Michel H
Clin Transplant; 1995 Feb; 9(1):65-9. PubMed ID: 7742585
[TBL] [Abstract][Full Text] [Related]
16. Fatal graft-versus-host disease after living donor liver transplantation: differential impact of donor-dominant one-way HLA matching.
Kamei H; Oike F; Fujimoto Y; Yamamoto H; Tanaka K; Kiuchi T
Liver Transpl; 2006 Jan; 12(1):140-5. PubMed ID: 16382466
[TBL] [Abstract][Full Text] [Related]
17. Treatment of graft-versus-host disease with mesenchymal cells as a complication of a liver transplantation.
Mora L; Alegre F; Rifón JJ; Martí P; Herrero JI
Rev Esp Enferm Dig; 2018 Nov; 110(11):734-736. PubMed ID: 30284904
[TBL] [Abstract][Full Text] [Related]
18. Graft Versus Host Disease After Liver Transplantation in Adults: A Case series, Review of Literature, and an Approach to Management.
Murali AR; Chandra S; Stewart Z; Blazar BR; Farooq U; Ince MN; Dunkelberg J
Transplantation; 2016 Dec; 100(12):2661-2670. PubMed ID: 27495762
[TBL] [Abstract][Full Text] [Related]
19. Absence of peripheral blood chimerism in graft-vs-host disease following orthotopic liver transplantation: case report and review of the literature.
Schulman JM; Yoon C; Schwarz J; Vagefi PA; Mully TW; Shinkai K
Int J Dermatol; 2014 Nov; 53(11):e492-8. PubMed ID: 24372059
[TBL] [Abstract][Full Text] [Related]
20. Case report: Rare persistent complete donor chimerism and GVHD following micro-transplantation from HLA haplotype homozygous donors.
Liu L; Cui Q; Li M; Li Z; Chen S; Ma Y; He J; Wu D; Tang X
Front Immunol; 2022; 13():1005364. PubMed ID: 36189257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
